For
p
atients
For
r
esearch sites
Find a trial
Researchers
Sponsors
Patients
Company
Log in
Get started
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)